{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:26:34Z","timestamp":1793183194276,"version":"4.5.0"},"reference-count":45,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,27]],"date-time":"2009-04-27T00:00:00Z","timestamp":1240790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>A committee assembled by the American Academy of Neurology (AAN) reassessed the evidence related to the care of women with epilepsy (WWE) during pregnancy, including preconceptional folic acid and prenatal vitamin K use and the clinical implications of placental and breast\u2010milk transfer of antiepileptic drugs (AEDs). The committee evaluated the available evidence based on a structured literature review and classification of relevant articles. Preconceptional folic acid supplementation is possibly effective in preventing major congenital malformations in the newborns of WWE taking AEDs. There is inadequate evidence to determine if the newborns of WWE taking AEDs have a substantially increased risk of hemorrhagic complications. Primidone and levetiracetam probably transfer into breast milk in clinically important amounts. Valproate, phenobarbital, phenytoin, and carbamazepine probably are not transferred into breast milk in clinically important amounts. Pregnancy probably causes an increase in the clearance and a decrease in the concentrations of lamotrigine, phenytoin, and, to a lesser extent carbamazepine, and possibly decreases the level of levetiracetam and the active oxcarbazepine metabolite, the monohydroxy derivative (MHD). Supplementing WWE with at least 0.4\u2003mg of folic acid before pregnancy may be considered. Monitoring of lamotrigine, carbamazepine, and phenytoin levels during pregnancy should be considered, and monitoring of levetiracetam and oxcarbazepine (as MHD) levels may be considered. A paucity of evidence limited the strength of many recommendations.<\/jats:p>","DOI":"10.1111\/j.1528-1167.2009.02130.x","type":"journal-article","created":{"date-parts":[[2009,5,2]],"date-time":"2009-05-02T15:08:50Z","timestamp":1241276930000},"page":"1247-1255","source":"Crossref","is-referenced-by-count":140,"title":["Management issues for women with epilepsy\u2014Focus on pregnancy (an evidence\u2010based review): III. Vitamin K, folic acid, blood levels, and breast\u2010feeding"],"prefix":"10.1111","volume":"50","author":[{"given":"Cynthia L.","family":"Harden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Page B.","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Koppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin A.","family":"Hovinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Gidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimford J.","family":"Meador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia Y.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. A.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Thurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian N.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Wilner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Krumholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Finnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia O.","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L.","family":"Le Guen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.91.5.1001","article-title":"Controversies concerning vitamin K and the newborn","volume":"91","author":"American Academy of Pediatrics Vitamin K Ad Hoc Task Force","year":"1993","journal-title":"Pediatrics"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1987.tb05464.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198510030-00007"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(95)00012-Y"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.1999.0325"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.01.041"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000240047.11166.0e"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20086"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03501.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198409000-00002"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199512000-00011"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181a6b2f8"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000252807.38124.a3"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104123441504"},{"key":"e_1_2_8_16_1","first-page":"291","article-title":"Placental transfer of anticonvulsants (phenobarbital, phenytoin, valproic acid) and elimination from neonates","volume":"1","author":"Ishizaki T","year":"1981","journal-title":"Pediatr Pharmacol"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.54804.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.4.549"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000044157.28073.DC"},{"key":"e_1_2_8_20_1","first-page":"199","article-title":"Carbamazepine and carbamazepine\u201010, 11\u2010epoxide during pregnancy and postnatal period in epileptic mothers and their nursed infants: clinical and pharmacokinetic effects","volume":"3","author":"Kuhnz W","year":"1983","journal-title":"Pediatr Pharmacol"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02528.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000457682","article-title":"Primidone and phenobarbital during lactation period in epileptic women: total and free drug levels in the nursed infants and their effects on neonatal behavior","volume":"11","author":"Kuhnz W","year":"1988","journal-title":"Dev Pharmacol Ther"},{"key":"e_1_2_8_23_1","first-page":"71","article-title":"The clearance of anticonvulsant drugs in pregnancy","volume":"17","author":"Lander CM","year":"1981","journal-title":"Clin Exp Neurol"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00459.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(71)80025-2"},{"key":"e_1_2_8_26_1","first-page":"1","article-title":"Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects","author":"Morbidity and Mortality Weekly Report","year":"1992","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.14301.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561476"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(25)32875-2","article-title":"Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother\u2019s milk and clinical status in neonates of epileptic mothers","volume":"219","author":"Nau H","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80567-3"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb00232.x"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.12502.x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.00251.x"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000103286.47129.F8"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000289511.20864.2a"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198212000-00001"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(92)90070-A"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02921.x"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01032.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.2.251"},{"key":"e_1_2_8_41_1","unstructured":"United States Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics Bridged\u2010Race Population Estimates United States(2007)July 1st resident population by state county age sex bridged\u2010race and Hispanic origin on CDC WONDER On\u2010line Database.http:\/\/wonder.cdc.gov."},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0967-5868(03)00158-9"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2004.05.003"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000154516.43630.C5"},{"key":"e_1_2_8_45_1","first-page":"S21","article-title":"Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy","volume":"55","author":"Yerby MS","year":"2000","journal-title":"Neurology"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(90)90042-T"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1167.2009.02130.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1167.2009.02130.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T07:28:17Z","timestamp":1739086097000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1167.2009.02130.x"}},"subtitle":["Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society"],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1528-1167.2009.02130.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02130.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}